Sofosbuvir-velpatasvir successful in hep C regardless of genotype

Sofosbuvir-velpatasvir successful in hep C regardless of genotype
(HealthDay)—Sofosbuvir-velpatasvir is effective for hepatitis C virus (HCV), regardless of genotype, according to three studies published online Nov. 17 in the New England Journal of Medicine. The research was published to coincide with the annual …
Read more here.

AbbVie's TECHNIVIE™ Receives Health Canada Approval for Genotype 4 Chronic
"Over the last several years, there has been a major focus on hepatitis C genotype 1 disease. The optimal protocol for treating hepatitis C genotype 4 patients was not well defined. As a practicing hepatologist, I am thrilled that finally there is a …
Read more here.

Liver cancer risk will remain elevated for people with cirrhosis cured of
The burden of liver cancer and cirrhosis caused by hepatitis C is likely to continue to grow in the United States despite curative treatment for hepatitis C, and people who have cirrhosis at the time they are cured of hepatitis C will require long-term …
Read more here.

HCV: 4 Weeks Too Short for Treatment With New Drugs
Four weeks of triple or quadruple combination therapy using new drugs for hepatitis C virus (HCV) results in only limited cure rates in patients with early-stage liver fibrosis, according to a study published online November 23 in the Annals of …
Read more here.

Sofosbuvir/ledipasvir for 8 weeks cures most hard-to-treat hepatitis C
The advent of direct-acting antiviral agents (DAAs) in interferon-free regimens has brought about a revolution in hepatitis C treatment, but there is still room to improve therapy, for example making treatment shorter and offering better options for …
Read more here.

Why doctors say all baby boomers should be tested for hepatitis C
Two weeks into it, he heard the word that is music to hep C patients' ears; his blood was “clear” of hep C. He was cured. “I'm happy to be alive,” Lo Russo said. He bowls in three leagues, swims and chats with fellow patients on Facebook. About 2.7 …
Read more here.

Daclatasvir, Sofosbuvir, Ribavirin Effective in Hep C Type 3
SAN FRANCISCO — For patients with hepatitis C genotype 3 infection, a virtual cure is achieved by most patients treated with the combination of daclatasvir, sofosbuvir, and ribavirin, a new study shows. "We can say that daclatasvir plus sofosbuvir …
Read more here.

Interferon-Free, Direct-acting Antiviral Therapy for Chronic Hepatitis C
The treatment environment for chronic hepatitis C has undergone a revolution, particularly in genotype 1. Gone are interferon-based therapy and its associated tolerability challenges, inadequate response rates and numerous baseline factors that affect …
Read more here.

Liver fibrosis improves after successful treatment for hepatitis C
Prior studies have shown that treatment with interferon-based therapy for hepatitis C, as well as tenofovir (Viread) for hepatitis B, can lead to some reversal of fibrosis and reduced risk of hepatocellular carcinoma and liver-related death. Direct …
Read more here.


Leave a Reply